AstraZeneca Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	211,432	213,845	162,287	164,292	173,826	134,436
Market Cap Growth	27.43%	31.77%	-1.22%	-5.49%	29.30%	39.84%
Enterprise Value	231,428	232,118	182,260	184,338	197,853	154,735
Last Close Price	136.32	136.48	101.41	100.48	104.16	78.72
PE Ratio	27.11	28.15	28.88	35.14	63.70	1625.31
Forward PE	17.10	18.34	14.36	17.08	18.65	18.61
PS Ratio	4.62	4.90	3.76	4.57	4.72	4.87
PB Ratio	5.89	5.91	4.97	5.34	5.65	4.63
P/FCF Ratio	24.72	24.46	20.45	23.29	24.03	37.36
P/OCF Ratio	19.63	19.75	17.13	20.23	21.35	30.53
PEG Ratio	1.47	1.54	1.17	1.47	1.29	0.95
EV/Sales Ratio	5.06	5.32	4.22	5.13	5.38	5.60
EV/EBITDA Ratio	14.99	16.20	12.99	16.45	17.35	31.27
EV/EBIT Ratio	20.49	21.86	17.65	24.21	27.05	72.32
EV/FCF Ratio	27.06	26.55	22.96	26.14	27.35	43.01
Debt / Equity Ratio	0.72	0.61	0.75	0.76	0.84	0.85
Debt / EBITDA Ratio	1.67	1.51	1.70	2.04	2.23	4.81
Debt / FCF Ratio	3.01	2.53	3.07	3.30	3.57	6.85
Net Debt / Equity Ratio	0.56	0.49	0.61	0.61	0.67	0.69
Net Debt / EBITDA Ratio	1.32	1.24	1.42	1.67	1.81	4.02
Net Debt / FCF Ratio	2.33	2.04	2.51	2.65	2.86	5.54
Asset Turnover	0.55	0.54	0.53	0.46	0.44	0.44
Inventory Turnover	1.80	1.81	1.80	1.59	1.26	1.85
Quick Ratio	0.70	0.65	0.67	0.58	0.62	0.67
Current Ratio	0.91	0.94	0.93	0.82	0.86	1.16
Return on Equity (ROE)	23.48%	22.84%	17.59%	15.64%	8.63%	0.42%
Return on Assets (ROA)	8.47%	8.19%	7.88%	6.13%	5.46%	2.10%
Return on Invested Capital (ROIC)	16.40%	17.03%	16.27%	13.42%	13.75%	6.00%
Return on Capital Employed (ROCE)	18.30%	17.10%	17.00%	13.70%	12.60%	3.50%
Earnings Yield	3.72%	3.55%	3.46%	2.85%	1.57%	0.06%
FCF Yield	4.04%	4.09%	4.89%	4.29%	4.16%	2.68%
Dividend Yield	1.73%	1.74%	2.44%	2.27%	2.31%	2.69%
Payout Ratio	46.07%	47.39%	65.47%	75.42%	132.72%	3442.86%
Buyback Yield / Dilution	0.08%	0.06%	-0.06%	-0.13%	-9.32%	-8.68%
Total Shareholder Return	1.80%	1.81%	2.38%	2.14%	-7.01%	-5.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.